Lung Cancer Foundation of America logo
Donate
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • DEI Commitment
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Hope
  • Research
  • Life
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • DEI Commitment
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Donate
  • Hope
  • Research
  • Life

What Can We Help You Find?

Archives: Awarded Grants

Jonathan Villena-Vargas, MD

Read More
|
February 28, 2023
|

Jacob Kaufman, PhD

Read More
|
January 14, 2022
|

Ramin Salehi-Rad, MD, PhD

Read More
|
January 14, 2022
|

Adrian Sacher, MD

Read More
|
December 29, 2020
|

Vincent Lam, MD

Read More
|
December 29, 2020
|

Jon Zugazagoitia, MD, PhD

Read More
|
April 23, 2020
|

Triparna Sen, PhD

Read More
|
April 23, 2020
|

Jarushka Naidoo, MRCPI

Read More
|
September 20, 2019
|

Daniel J. Spakowicz, PhD

Read More
|
September 20, 2019
|

Haiying Cheng, MD, PhD

Read More
|
October 24, 2018
|
1 2 Next »

Or Search Our Site By Topic:

adenocarcinoma Advocacy advocacy ALK+ awareness biomarker biomarker testing chemotherapy clinical trial Clinical Trials clinical trials combination therapy Detection Diagnosis diagnosis early detection EGFR EGFR mutation Fundraising genomic testing immunotherapy Immunotherapy KRAS latest research Living with Lung Cancer Lung Cancer Info lung cancer research non-smoker NSCLC patient support personalized medicine radiation Research ROS1 SCLC small cell lung cancer speakers bureau stage 4 Survivors Targeted therapy targeted therapy Treatment treatment Tributes Uncategorized

More

  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • DEI Commitment
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy

Give with Confidence


      

Our Mission

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.



Latest In Research

11/15
2023

FDA Approves Repotrectinib for Locally Advanced or Metastatic ROS1+ NSCLC

The FDA has approved repotrectinib (Augtyro) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer. SUMMARY: The Food and Drug Administration (FDA) recently approved a new dru…

Sign up

Get the latest news about lung cancer research.

Connect with us



©2023 Lung Cancer Foundation of America. All Rights Reserved. EIN 20-8730839

Sponsors    |    Legal and Privacy    |    Media Contact    |   State Fundraising Notices